KEAP1 mutations as key crucial prognostic biomarkers for resistance to KRAS-G12C inhibitors
2025 · Journal of Translational Medicine · 6 citations
https://doi.org/10.1186/s12967-025-06089-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
11
Citations
2
h-index
0
i10-index
Huiyang Shi is an academic researcher from Zhejiang Chinese Medical University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & RNA modifications and cancer & Melanoma and MAPK Pathways. The author has an h-index of 2, co-authored 10 publications.
https://doi.org/10.1186/s12967-025-06089-y
https://doi.org/10.1186/s12967-024-05926-w
Click to start Chat